Smartphone Technology to Alleviate Malignant Pain (STAMP)

The purpose of the study is to develop the STAMP app (Smartphone Technology to Alleviate
Malignant Pain). This app will be used by patients with advanced cancer to track symptoms and
receive tailored symptom management advice. This project will involve 4 specific activities:

1. Activity 1 - Content Development (working groups)

2. Activity 2 - Programming and testing of app algorithms

3. Activity 3 - User acceptability testing

4. Activity 4 - Pilot testing

Activities 1 and 2 will involve the development of the content and functionalities for the
STAMP app. Activity 3 (the user acceptability testing phase of the project) will be conducted
to identify and address any problems with the developed tool. User acceptability testing will
involve interviews and focus groups with patients and providers who have been shown the app.
The information gathered from these interviews and groups will be used to improve the
application before it undergoes pilot testing. Activity 4 (pilot testing) will be conducted
to demonstrate the utilization and efficacy of the STAMP app among patients with chronic
cancer pain and their cancer care providers.

Inclusion Criteria:

Activity 3 Patient Inclusion Criteria:

- Patient in the DFCI gastrointestinal cancer center (GCC), breast oncology OR thoracic
oncology programs.

- Age ≥21

- Diagnosed with metastatic cancer

- Currently on short and long-acting opioids for cancer pain

- Own a smartphone.

Activity 3 Clinician Inclusion Criteria:

-Palliative and oncology physicians, mid-level providers, and nurses from across DFCI solid
tumor programs

Activity 4 Patient Inclusion Criteria:

- Patient in the DFCI gastrointestinal cancer center (GCC)

- Age ≥21

- Diagnosed with incurable GI cancer

- Chronic pain rated >4/10 within the last week

- Have initiated or up-titrated a short and long-acting opioid within the last 2 weeks

- Own a smartphone.

Activity 4 Clinician Inclusion Criteria:

-Palliative and oncology physicians (and their NPs)

Exclusion Criteria:

Activity 3 Patient Exclusion Criteria:

- Cognitive impairment

- Inability to speak English

- History of substance abuse

Activity 3 Clinician Exclusion Criteria:

-Unwilling to participate

Activity 4 Patient Exclusion Criteria:

- Cognitive impairment

- Inability to speak English

- History of substance abuse

- Enrolled on hospice

- Currently hospitalized

- Use of >300mg oral morphine equivalents per day, or opioids not supported by STAMP
(e.g. methadone)

- Diagnosed with a bowel obstruction

- The following special populations are excluded: adults unable to consent, prisoners,
and pregnant women.

Activity 4 Clinician Exclusion Criteria:

-Unwilling to participate